5-Amino-1MQ Key Research Facts Chemical name: 5-Amino-1-Methylquinolinium (also abbreviated as 5A-1MQ or 5MQ) Target enzyme: Nicotinamide N-Methyltransferase (NNMT) Mechanism: Competitive inhibition of NNMT reduces 1-MNA production, preserves nicotinamide for NAD+ synthesis and SAM for epigenetic methylation Selectivity: High selectivity for NNMT does not inhibit related SAM-dependent methyltransferases or NAD+ salvage pathway enzymes Membrane permeability: High passive and active transport permeability confirmed in PAMPA and Caco-2 cell assays NNMT expression: Upregulated in obese adipose tissue, multiple cancer types, and aged skeletal muscle tissue contexts of primary research interest Downstream targets: NAD+ availability, SIRT1/SIRT3 activity, SAM-dependent epigenetic methylation, lipogenesis, energy expenditure Pre-clinical models: Diet-induced obese (DIO) mice, 3T3-L1 adipocyte cell models, aged mouse skeletal muscle models, HeLa cancer cell lines In vitro cell viability: No impact on cell viability at 10 M concentration in 3T3-L1 pre-adipocytes in published toxicity profiling What Does 5-Amino-1MQ Do in Research

This review paper summarizes the research findings for NAD+ boosters and brain health, highlighting positive benefits for cognitive function and brain aging in animal models
A 50 mg vial mixed with 3.0 mL of bacteriostatic water gives about 16.7 mg/mL, and the example subcutaneous range is 2.5 to 5 mg per day
The compounds ability to promote fat loss while preserving muscle mass makes it attractive for athletes, but competitive athletes must prioritize compliance with anti-doping regulations
B12 Form Choice Should Match the Reason for Treatment Methylcobalamin may be preferred when nerve-related symptoms, methylation issues, or persistent fatigue remain part of the clinical picture
Hydroxocobalamin and pregnancy